This is exciting research. I’ll bet scientists at such companies as Allergan, Alcon, and Bausch & Lomb are already trying to figure out how to cash in on the commercialization of AMD diagnostics.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”